| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 8e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.52 | 0.005 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.46 | 0.006 |